Related Experiment Video
Updated: Nov 25, 2025

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
[Autosomal dominant polycystic kidney disease : a pediatric perspective]
A Dachy1, L Collard1,2, J M Krzesinski3
1Service de Pédiatrie, CHU Liège, Belgique.
Insights
Polycystic kidney disease (PKD) is a common inherited kidney disorder. Identifying early predictive markers in children is crucial for slowing disease progression and preserving kidney function.
Area of Science:
- Nephrology
- Genetics
- Pediatrics
Background:
- Polycystic kidney disease (PKD) is the most common inherited kidney disease, typically presenting in adulthood.
- Renal cyst development begins in childhood, yet screening protocols for pediatric patients remain undefined.
- Tolvaptan is an approved treatment for slowing PKD progression in adults.
Purpose of the Study:
- To investigate the need for early predictive markers of renal function decline in pediatric patients with PKD.
- To explore potential early indicators for slowing the progression of polycystic kidney disease in children.
Main Methods:
- Review of current scientific literature on PKD progression and pediatric screening.
- Analysis of animal model studies demonstrating the impact of early intervention on cyst growth.
- Examination of the efficacy of tolvaptan in adult PKD patients.
Main Results:
- PKD cyst formation starts early in life, suggesting a window for intervention.
- Animal models indicate that inhibiting cyst growth can decelerate renal function decline.
- Current adult treatments like tolvaptan highlight the potential for therapeutic strategies in slowing PKD.
Conclusions:
- Early identification of predictive markers in children is essential for proactive PKD management.
- Developing pediatric screening strategies could significantly impact long-term renal health outcomes.
- Further research is warranted to establish consensus on pediatric PKD screening and early intervention.
Abstract:
Polycystic kidney disease (PKD) is the most prevalent inherited kidney disease. The disease is usually asymptomatic until adulthood. End-stage renal disease occurs generally after the age of 55 years, with a large inter-individual variability. Renal cyst formation begins early in life, and animal models have shown that treatments able to prevent the cyst growth slow down the renal function decline. A treatment by tolvaptan is currently used in adults to decelerate PKD progression. Until now there is no consensus about the appropriate time to screen for PKD in children. However, these scientific progresses raise the interest of determining early (i.e. pediatric) predictive markers of renal function decline.
More Related Videos
Related Concept Videos
Chronic Kidney Disease I: Introduction
Nephrons
Chronic Kidney Disease III: Interprofessional Care
Pharmacokinetics in Pediatric Patients: Drug Excretion
Renal Tubule and Collecting Duct
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...
Nephrotic Syndrome I : Introduction

